Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-15-086747

Options or other derivatives

  • President and CEO acquired 149,035 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Walker Neal President and CEO 2015-12-18 Grant or award · Stock option (right to buy) +137,335 137,335 D
Walker Neal President and CEO 2015-12-18 Grant or award · Restricted stock units +11,700 11,700 D
Loading xslF345X03/doc4.xml…